PASG (STOCKS)
Passage Bio, Inc. Common Stock
$8.730000
-0.030000 (-0.34%)
Prev close: $8.760000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- William Chou
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $26.52M
- Employees
- 60
- P/E (TTM)
- -0.60
- P/B (TTM)
- 0.89
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
4
Strong Buy
7
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$-2.44 | $-2.86 | +0.4160 | +14.57% |
|
Jun 2025 (Q2)
|
$-2.96 | $-4.13 | +1.1710 | +28.35% |
|
Mar 2025 (Q1)
|
$-5.00 | $-4.69 | -0.3080 | -6.56% |
|
Dec 2024 (Q4)
|
$-4.00 | $-4.16 | +0.1616 | +3.88% |
Financial Statements
| Research and Development | $27.42M |
| Operating Income/Loss | -$49.72M |
| Income/Loss From Continuing Operations After Tax | -$45.26M |
| Income/Loss From Continuing Operations Before Tax | -$45.26M |
| Net Income/Loss | -$45.26M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$45.26M |
| Net Income/Loss Available To Common Stockholders, Basic | -$45.26M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $5.71 |
| Diluted Earnings Per Share | $5.71 |
| Basic Average Shares | 60,521,169 |
| Diluted Average Shares | 60,521,169 |
| Assets | $74.16M |
| Current Assets | $55.73M |
| Noncurrent Assets | $18.43M |
| Fixed Assets | $5.16M |
| Other Non-current Assets | $13.27M |
| Liabilities | $43.04M |
| Current Liabilities | $22.25M |
| Accounts Payable | $952.00K |
| Wages | $2.99M |
| Other Current Liabilities | $18.31M |
| Noncurrent Liabilities | $20.80M |
| Equity | $31.12M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $31.12M |
| Liabilities And Equity | $74.16M |
| Net Cash Flow From Operating Activities | -$33.47M |
| Net Cash Flow From Operating Activities, Continuing | -$33.47M |
| Net Cash Flow From Investing Activities | $53.89M |
| Net Cash Flow From Investing Activities, Continuing | $53.89M |
| Net Cash Flow From Financing Activities | $61.00K |
| Net Cash Flow From Financing Activities, Continuing | $61.00K |
| Net Cash Flow | $20.48M |
| Net Cash Flow, Continuing | $20.48M |
| Comprehensive Income/Loss | -$45.30M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$45.30M |
| Other Comprehensive Income/Loss | -$45.30M |